Volume 28, Issue 5 (Iran South Med J 2026)
Iran South Med J 2026, 28(5): 838-849 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Honarmandi M, Zakariaee S S. Diagnostic Performance of Semi-Quantitative Indices of Dynamic T1-Weighted Magnetic Resonance Imaging for Presurgical Glioma Grading. Iran South Med J 2026; 28 (5) :838-849
URL: http://ismj.bpums.ac.ir/article-1-2452-en.html
URL: http://ismj.bpums.ac.ir/article-1-2452-en.html
1- Department of Radiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran
2- Department of Medical Physics, School of Paramedical Sciences, Ilam University of Medical Sciences, Ilam, Iran ,zakariaee-s@medilam.ac.ir
2- Department of Medical Physics, School of Paramedical Sciences, Ilam University of Medical Sciences, Ilam, Iran ,
Abstract: (111 Views)
Background: In recent years, complementary methods, including imaging-based approaches, have been proposed for better grading of glioma tumors due to the inherent limitations of histopathology as the standard method. This study aimed to determine the diagnostic performance of semi-quantitative parameters of dynamic T1-weighted magnetic resonance imaging (T1W-MRI) for presurgical glioma grading.
Materials and Methods: Patients with brain tumors referred to the imaging department of a referral cancer center between February 2021 and July 2023 were retrospectively reviewed. Thirty-one patients with glioma confirmed by pathology results met the inclusion criteria. The mean age of the patients was 39.2±1.14 years, and 18 participants were male (58.06%). Semi-quantitative parameters (IAUC, Peak, and Initial Slope) were quantified using dynamic T1W-MRI data. The Mann-Whitney U test was used to assess the significance of the difference between these parameters in different grades of glioma. The performance of these parameters for glioma grading was evaluated using receiver operating characteristic (ROC) curve analysis.
Results: IAUC, Peak, and Initial slope parameters showed significant differences between different glioma grades (P≤0.041), and the results indicated that IAUC had the best grading performance compared to the other studied parameters.
Conclusion: Semi-quantitative parameters quantified using dynamic T1W-MRI are valuable indices that can reliably discriminate between glioma grades. These non-invasive physiological imaging parameters can serve as a powerful complement to the standard histopathological grading system.
Materials and Methods: Patients with brain tumors referred to the imaging department of a referral cancer center between February 2021 and July 2023 were retrospectively reviewed. Thirty-one patients with glioma confirmed by pathology results met the inclusion criteria. The mean age of the patients was 39.2±1.14 years, and 18 participants were male (58.06%). Semi-quantitative parameters (IAUC, Peak, and Initial Slope) were quantified using dynamic T1W-MRI data. The Mann-Whitney U test was used to assess the significance of the difference between these parameters in different grades of glioma. The performance of these parameters for glioma grading was evaluated using receiver operating characteristic (ROC) curve analysis.
Results: IAUC, Peak, and Initial slope parameters showed significant differences between different glioma grades (P≤0.041), and the results indicated that IAUC had the best grading performance compared to the other studied parameters.
Conclusion: Semi-quantitative parameters quantified using dynamic T1W-MRI are valuable indices that can reliably discriminate between glioma grades. These non-invasive physiological imaging parameters can serve as a powerful complement to the standard histopathological grading system.
Keywords: Glioma, Tumor grading, Contrast-enhanced magnetic resonance imaging, Semi-quantitative parameters
Type of Study: Original |
Subject:
Radiology
Received: 2025/11/23 | Accepted: 2026/02/24 | Published: 2026/05/25
Received: 2025/11/23 | Accepted: 2026/02/24 | Published: 2026/05/25
References
1. Mesfin FB, Karsonovich T, Al-Dhahir MA. Gliomas. StatPearls [Internet]: StatPearls Publishing; 2024. [Article]
2. Schwartzbaum JA, Fisher JL, Aldape KD, et al. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2006; 2(9): 494-503. [DOI]
3. Larjavaara S, Mäntylä R, Salminen T, et al. Incidence of gliomas by anatomic location. Neuro Oncol 2007; 9(3): 319-325. [DOI]
4. Pellerino A, Caccese M, Padovan M, et al. Epidemiology, risk factors, and prognostic factors of gliomas. Clin Transl Imaging 2022; 10(5): 467-475. [DOI]
5. Zakariaee SS, Hashemi H, Salmanipour H. Comparison of singular value decomposition and Fourier deconvolution methods for cerebral blood flow quantification in dynamic contrastenhanced magnetic resonance imaging. J Res Med Sci 2022; 9(4): 57-68. [DOI]
6. Zakariaee SS, Oghabian MA, Firouznia K, et al. Assessment of the agreement between cerebral hemodynamic indices quantified using dynamic susceptibility contrast and dynamic contrastenhanced perfusion magnetic resonance imagings. J Clin Imaging Sci 2018; 8: 1-9. [DOI]
7. Muragaki Y, Chernov M, Maruyama T, et al. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate? Minim Invasive Surg 2008; 51(5): 275-279. [DOI]
8. Jackson RJ, Fuller GN, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol 2001; 3(3): 193-200. [DOI]
9. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24(10): 1989-1998. [Article]
10. Abdi AI. Glioma grading using an optimized T1-weighted dynamic contrastenhanced magnetic resonance imaging paradigm. Egypt J Radiol Nucl Med 2024; 55(1): 1-12. [DOI]
11. Eilaghi A, Yeung T, d'Esterre C, et al. Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images: Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies. Biomark Cancer 2016; 8(Suppl 2): 47-59. [DOI]
12. Aydin S, Fatihoğlu E, Koşar PN, et al. Perfusion and permeability MRI in glioma grading. Egypt J Radiol Nucl Med 2020; 51(1): 1-8. [DOI]
13. Ma H, Zeng S, Huang Y, et al. Predicting glioma histomolecular diagnosis and prognosis: preoperative dynamic contrast-enhanced magnetic resonance imaging insights. Quant Imaging Med Surg 2025; 15(10): 9855-9870. [DOI]
14. Association WM. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama 2013; 310(20): 2191-2194. [DOI]
15. Walke V, Joshi D, Sharma T, et al. The spectrum of microvascular patterns in adult diffuse glioma and their correlation with tumor grade. J Pathol Transl Med 2024; 58(3): 127-133. [DOI]
16. Muthukrishnan SD, Qi H, Wang D, et al. Low-and high-grade glioma-associated vascular cells differentially regulate tumor growth. Mol Cancer Res 2024; 22(7): 656-667. [DOI]
17. Zhao J, Yang ZY, Luo BN, et al. Quantitative evaluation of diffusion and dynamic contrast-enhanced MR in tumor parenchyma and peritumoral area for distinction of brain tumors. PLoS One 2015; 10(9): e0138573. [DOI]
18. Mills SJ, Soh C, O’connor JP, Rose CJ, Buonaccorsi GA, Cheung S, Zhao S, Parker GJ, Jackson A. Tumour enhancing fraction (EnF) in glioma: relation-ship to tumour grade. European Radiology 2009; 19(6): 1489-1498. [DOI]
Send email to the article author
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
